(Q33337284)

25 July 2017

1 reference

title

Heparin in the treatment of burns: a review (English)

1 reference

25 July 2017

1 reference

Saliba MJ Jr

1

1 reference

25 July 2017

publication date

1 June 2001

1 reference

25 July 2017

1 reference

25 July 2017

volume

27

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

page(s)

349-358

1 reference

Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Histamine binding by heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

PHYSIOLOGIC ACTIONS OF HEPARIN NOT RELATED TO BLOOD CLOTTING.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

HEPARIN IN THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCHOPULMONARY DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

THE CLINICAL USAGE OF HEPARIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Large burns in humans. Treatment with heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Effect of heparin in anticoagulant doses on the electrocardiogram and cardiac enzymes in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

The anti-inflammatory action of heparin: Heparin as an antagonist to histamine, bradykinin and prostaglandin E1

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

The interaction of platelets with a tritium-labelled heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

The production of lipolytic activity in the circulation of the hind limb in response to heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Sludged blood following severe thermal burns

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Reduction of bacterial translocation and intestinal structural alterations by heparin in a murine burn injury model.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Reduction of bacterial translocation with oral fibroblast growth factor and sucralfate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Mast cell heparin stimulates migration of capillary endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Studies on vascular smooth muscle cells and dermal fibroblasts in collagen matrices. Effects of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Vascularized collagen-glycosaminoglycan matrix provides a dermal substrate and improves take of cultured epithelial autografts

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Effects of cryopreservation and deconstruction on the dermal glycosaminoglycan content of human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

Part I. Pathophysiology of thermal burns. Microvascular pathophysiology of burned tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2800%2900130-3

7 January 2021

10.1016/S0305-4179(00)00130-3

Identifiers

DOI

1 reference

25 July 2017

1 reference